Alembic Pharmaceuticals secures final approval from FDA for hypertension drug

Pallavi Madhiraju- October 20, 2024

Alembic Pharmaceuticals Limited has successfully secured final approval from the US Food and Drug Administration (USFDA) for its Diltiazem Hydrochloride Extended-Release Capsules USP, in strengths ... Read More